Overview

ajmaline


'ajmaline' can also refer to...

ajmaline

Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges

The ajmaline challenge in Brugada syndrome A useful tool or misleading information?

‘Intrahepatic cholestatic hepatitis following diagnostic ajmaline challenge’

The ajmaline challenge and a strange ECG

The ajmaline challenge and a strange ECG: reply

Paradoxical effect of ajmaline in a patient with Brugada syndrome

Ventricular arrhythmia during ajmaline challenge for the Brugada syndrome

11.5 Diagnostic value of Ajmaline testing in arrhythmogenic right ventricular dysplasia-cardiomyopathy

The ajmaline challenge in Brugada syndrome: Diagnostic impact, safety, and recommended protocol

Unusual unmasking of Brugada syndrome electrocardiographic pattern during ajmaline test by leaning forward: a case report

Unusual response to the ajmaline test in a patient with Brugada syndrome

P-456 Diagnostic value of ajmaline testing in arrhythmogenic right ventricular dysplasia-cardiomyopathy

Quantitative Determination of Reserpine, Ajmaline, and Ajmalicine in Rauvolfia serpentina by Reversed- Phase High-Performance Liquid Chromatography

Subcutaneous implantable cardioverter-defibrillator and drug-induced Brugada syndrome: the importance of repeat morphology analysis during ajmaline challenge

Systematic ajmaline challenge in patients with long QT 3 syndrome caused by the most common mutation: a multicentre study

Should all individuals with a non-diagnostic electrocardiogram undergo ajmaline challenge to unmask the concealed arrhythmic overlap syndromes?

 

More Like This

Show all results sharing this subject:

  • Chemistry

GO

Show Summary Details

Quick Reference

Ajmalan‐17,20‐diol; an alkaloid from the roots of Rauwolfia serpentina. It is used clinically as an antihypertensive and antiarrhythmic, having the effect of normalizing heart rhythm.

Subjects: Chemistry.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.